Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal Golgi

Journal of Cellular Physiology

Volumn 220, Issue 3, 2009, Pages 640-654

  Sánchez Laorden, Berta L ^a   Herraiz, Cecilia ^a   Valencia, Julio C ^b   Hearing, Vincent J ^b   Jiménez Cervantes, Celia ^a   García Borrón, José C ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 1 RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CELL MEMBRANE; CELL STRAIN HEK293; ENDOPLASMIC RETICULUM; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; GOLGI COMPLEX; HAIR COLOR; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SKIN CANCER; AMINO ACID SEQUENCE; CELL LINE; GENETIC TRANSFECTION; GENETICS; MELANOCYTE; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN CONFORMATION; PROTEIN MOTIF; PROTEIN TRANSPORT; SKIN PIGMENTATION; SKIN TUMOR; STRUCTURE ACTIVITY RELATION; TIME;

MAMMALIA;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL LINE; CELL MEMBRANE; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HAIR COLOR; HUMANS; MELANOCYTES; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS; SKIN PIGMENTATION; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TRANSFECTION;

EID: 67650400328     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21804     Document Type: Article

References (62)

1. Ahner A, Brodsky JL. 2004. Checkpoints in ER-associated degradation: Excuseme, which way to the proteasome? Trends Cell Biol 14:474-478.
2. Anelli T, Sitia R. 2008. Protein quality control in the early secretory pathway. EMBO J 27:315-327.
3. Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA. 2005. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 14:2145-2154.
4. Beaumont KA, Shekar SN, Newton RA, James MR, Stow JL, Duffy DL, Sturm RA. 2007. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 16:2249-2260.
5. Bohm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Luger TA, Schwarz T, Schwarz A. 2005. Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795-5802.
6. Bohm M, Luger TA, Tobin DJ, Garcia-Borron JC. 2006. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J Invest Dermatol 126:1966-1975.
7. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. 1997. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 6:1891-1897.
8. Busca R, Ballotti R. 2000. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13:60-69.
9. Chakraborty AK, Orlow SJ, Bolognia JL, Pawelek JM. 1991. Structural/functional relationships between internal and external MSH receptors: Modulation of expression in Cloudman melanoma cells by UVB radiation. J Cell Physiol 147:1-6.
10. Conn PM, Ulloa-Aguirre A, Ito J, Janovick JA. 2007. G protein-coupled receptor trafficking in health and disease: Lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev 59:225-250.
11. Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, Moss SJ. 1998. Intracellular retention of recombinant GABAB receptors. J Biol Chem 273:26361-26367.
12. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. 2007. Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510.
13. Donaldson JG, Finazzi D, Klausner RD. 1992. Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature 360:350-352.
14. Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, Hayward NK, Martin NG, Sturm RA. 2004. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13:447-461.
15. Duvernay MT, Filipeanu CM, Wu G. 2005. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal 17:1457-1465.
16. Ellgaard L, Helenius A. 2003. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4:181-191.
17. Ghose-Dastidar J, Ross JB, Green R. 1991. Expression of biologically active human corticosteroid binding globulin by insect cells: Acquisition of function requires glycosylation and transport. Proc Natl Acad Sci USA 88:6408-6412.
18. Healy E, Flannagan N, Ray A, Todd C, Jackson IJ, Matthews JN, Birch-Machin MA, Rees JL. 2000. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355:1072-1073.
19. Healy E, Jordan SA, Budd PS, Suffolk R, Rees JL, Jackson IJ. 2001. Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 10:2397-2402.
20. Hermosilla R, Oueslati M, Donalies U, Schonenberger E, Krause E, Oksche A, Rosenthal W, Schulein R. 2004. Disease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway. Traffic 5:993-1005.
21. Huang C, Li J, Chen N, Ma W, Bowden GT, Dong Z. 2000. Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation. Mol Carcinog 27:65-75.
22. Ito S, Wakamatsu K. 2003. Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: A comparative review. Pigment Cell Res 16:523-531.
23. Jimenez-Cervantes C, Germer S, Gonzalez P, Sanchez J, Sanchez CO, Garcia-Borron JC. 2001a. Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett 508:44-48.
24. Jimenez-Cervantes C, Olivares C, Gonzalez P, Morandini R, Ghanem G, Garcia-Borron JC. 2001b. The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. J Invest Dermatol 117:156-158.
25. Kadekaro AL, Kavanagh R, Kanto H, Terzieva S, Hauser J, Kobayashi N, Schwemberger S, Cornelius J, Babcock G, Shertzer HG, Scott G, Abdel-Malek ZA. 2005. Alpha-melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65:4292-4299.
26. Lippincott-Schwartz J, Liu W. 2003. Membrane trafficking: Coat control by curvature. Nature 426:507-508.
27. Lippincott-Schwartz J, Liu W. 2006. Insights into COPI coat assembly and function in living cells. Trends Cell Biol 16:e1-e4.
28. Losev E, Reinke CA, Jellen J, Strongin DE, Bevis BJ,Glick BS. 2006. Golgi maturation visualized in living yeast. Nature 441:1002-1006.
29. Lotti LV, Torrisi MR, Erra MC, Bonatti S. 1996. Morphological analysis of the transfer of VSV ts-045 G glycoprotein from the endoplasmic reticulum to the intermediate compartment in vero cells. Exp Cell Res 227:323-331.
30. Margeta-Mitrovic M, Jan YN, Jan LY. 2000. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97-106.
31. Mas JS, Gerritsen I, Hahmann C, Jimenez-Cervantes C, Garcia-Borron JC. 2003. Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res 16:540-547.
32. Matsuura-Tokita K, Takeuchi M, Ichihara A, Mikuriya K, Nakano A. 2006. Live imaging of yeast Golgi cisternal maturation. Nature 441:1007-1010.
33. Michelsen K, Yuan H, Schwappach B. 2005. Hide and run. Arginine-based endoplasmic-reticulum-sorting motifs in the assembly of heteromultimeric membrane proteins. EMBO Rep 6:717-722.
34. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. 1992. The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251.
35. Moyer BD, Allan BB, Balch WE. 2001. Rab1 interaction with a GM130 effector complex regulates COPII vesicle cis-Golgi tethering. Traffic 2:268-276.
36. Newton Bishop JA, Bishop DT. 2005a. The genetics of susceptibility to cutaneous melanoma. Drugs Today (Barc) 41:193-203.
37. Newton RA, Smit SE, Barnes CC, Pedley J, Parsons PG, Sturm RA. 2005b. Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides 26:1818-1824.
38. Newton RA, Roberts DW, Leonard JH, Sturm RA. 2007. Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways. Peptides 28:2387-2396.
39. Nufer O, Hauri HP. 2003. ER export: Call 14-3-3. Curr Biol 13:R391-R393.
40. O'Kelly I, Butler MH, Zilberberg N, Goldstein SA. 2002. Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 111:577-588.
41. Oueslati M, Hermosilla R, Schonenberger E, Oorschot V, Beyermann M, Wiesner B, Schmidt A, Klumperman J, Rosenthal W, Schulein R. 2007. Rescue of a nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutant by cell-penetrating peptides. J Biol Chem 282:20676-20685.
42. Ouwendijk J, Moolenaar CE, Peters WJ, Hollenberg CP, Ginsel LA, Fransen JA, Naim HY. 1996. Congenital sucrase-isomaltase deficiency. Identification of a glutamine to proline substitution that leads to a transport block of sucrase-isomaltase in a pre-Golgi compartment. J Clin Invest 97:633-641.
43. Pérez-Oliva AB, Fernández LP, DeTorre C, Herraiz C, Martínez-Escribano JA, Benítez J, Lozano Teruel JA, García-Borrón JC, Jiménez-Cervantes C, Gloria Ribas R. 2009. Identification and functional analysis of novel variants of the human melanocortin receptor found in melanoma patients. Hum Mutat DOI: 10.1002/humu.20971.
44. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639-650.
45. Polo S, Di Fiore PP. 2006. Endocytosis conducts the cell signaling orchestra. Cell 124:897-900.
46. Rees JL. 2004. The genetics of sun sensitivity in humans. Am J Hum Genet 75:739-751.
47. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB. 2004. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 123:917-923.
48. Roberts DW, Newton RA, Beaumont KA, Helen LJ, Sturm RA. 2006. Quantitative analysis of MC1R gene expression in human skin cell cultures. Pigment Cell Res 19:76-89.
49. Rottger S, White J, Wandall HH, Olivo JC, Stark A, Bennett EP, Whitehouse C, Berger EG, Clausen H, Nilsson T. 1998. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J Cell Sci 111:45-60.
50. Rutkowski DT, Kaufman RJ. 2004. A trip to the ER: Coping with stress. Trends Cell Biol 14:20-28.
51. Sanchez MJ, Olivares SC, Ghanem G, Haycock J, Lozano Teruel JA, Garcia-Borron JC, Jimenez-Cervantes C. 2002. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 269:6133-6141.
52. Sanchez-Laorden BL, Sanchez-Mas J, Martinez-Alonso E, Martinez-Menarguez JA, Garcia-Borron JC, Jimenez-Cervantes C. 2006a. Dimerization of the human melanocortin 1 receptor: Functional consequences and dominant-negative effects. J Invest Dermatol 126:172-181.
53. Sanchez-Laorden BL, Sanchez-Mas J, Turpin MC, Garcia-Borron JC, Jimenez-Cervantes C. 2006b. Variant amino acids in different domains of the human melanocortin 1 receptor impair cell surface expression. Cell Mol Biol (Noisy-le-grand) 52:39-46.
54. Sanchez-Laorden BL, Jimenez-Cervantes C, Garcia-Borron JC. 2007. Regulation of human melanocortin 1 receptor signaling and trafficking by Thr-308 and Ser-316 and its alteration in variant alleles associated with red hair and skin cancer. J Biol Chem 282:3241-3251.
55. Sanchez-Mas J, Guillo LA, Zanna P, Jimenez-Cervantes C, Garcia-Borron JC. 2005. Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors. Mol Endocrinol 19:1035-1048.
56. Schutze MP, Peterson PA, Jackson MR. 1994. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J 13: 1696-1705.
57. Siegrist W, Stutz S, Eberle AN. 1994. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res 54:2604-2610.
58. Smith R, Healy E, Siddiqui S, Flanagan N, Steijlen PM, Rosdahl I, Jacques JP, Rogers S, Turner R, Jackson IJ, Birch-Machin MA, Rees JL. 1998. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 111:119-122.
59. Sturm RA. 2002. Skin colour and skin cancer-MC1R, the genetic link. Melanoma Res 12:405-416.
60. Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG. 2003a. The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16:266-272.
61. Sturm RA, Duffy DL, Box NF, Newton RA, Shepherd AG, Chen W,Marks LH, Leonard JH, Martin NG. 2003b. Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann N Y Acad Sci 994:348-358.
62. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. 1995. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328-330.